Shingles vaccine and its effect on lung cancer patients
Part of Cancer, Lungs & breathing clinical trials.
This study looks at whether getting a shingles vaccine (which helps prevent shingles) might affect how lung cancer patients do over time, including their survival. It's an observational study, so you won't receive any new treatments; researchers will just track your health if you choose to get the vaccine as part of your regular care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a diagnosis of lung cancer (either non-small cell or small cell type).
- Your lung cancer can be at any stage, and you can have had any prior treatments (surgery, radiation, chemo, or none).
- You have never received a shingles (herpes zoster) vaccine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether the Shingrix vaccine (which protects against shingles) works well and is safe in people with chronic lymphocytic leukemia (CLL). The vaccine may help boost your immune system's ability to fight off shingles, a common and painful infection for CLL patients.
This Phase 4 study checks how safe a shingles vaccine (Shingrix, a non-live vaccine) is for adults with lupus. You might be invited if you have lupus and haven’t had certain shingles or chickenpox-related vaccines recently, and if your lupus symptoms and immune health meet the study rules.
This study is looking at how getting the shingles vaccine affects your quality of life and the overall burden of the disease. Researchers will track your health over time to understand what life is like after vaccination versus not.
This trial tests an experimental vaccine designed to prevent shingles (a painful rash caused by the varicella-zoster virus). It will help see if the vaccine is safe and triggers a good immune response in adults 40 and older.
This trial tests a new shingles vaccine in adults 40 and older to see if it is safe and works well. The vaccine is designed to prevent shingles and its complications, which are common in this age group.
This trial tests a new shingles vaccine for healthy adults 40 and older. It aims to see if the vaccine is safe and helps protect against shingles.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.